We have received your feedback.Thank you for taking your time in view of your busy schedule.
| Weekly News | Amount |
|---|---|
|
Total
|
${lastRankDetail.pages.length} |
| Financing | ${lastRankDetail.financing_pages.length} |
| Product | ${lastRankDetail.product_pages.length} |
| Negative | ${lastRankDetail.sentiment_pages.length} |
BociMed is an enterprise engaged in drug research and development and clinical research. It provides high-quality research and development and outsourcing services including drug discovery, preclinical pharmaceutical research and development, clinical phase I-IV trials and registration declaration for enterprises through the establishment of a standardized service system
Transactions
Research
Competition
Transactions
Funding
2 Fundings
| Date | Amount | Round | Relative News |
|---|---|---|---|
| Feb 2019 | Tens of millions CNY | Series A | BociMed completed tens of millions of Series A financing, and Shanghai Science and Technology Venture Capital Group and Xingfu Capital invested |
| Oct 2020 | Undisclosed | Series B | BociMed completed the B round of financing of over 100 million yuan |
Signals
Events
${currentEventsPage.count} Events
| Events (${currentEventsPage.count}) | Date |
|---|---|
| Nothing Happens :-( | |
| ${e.desp} | ${e.date} |
News
${ rankDetail.pages.length } News Articles
${currentTimeRange.start} ~ ${currentTimeRange.end}
| Article (${rankDetail.pages.length}) | Tag |
|---|---|
| ${article.en_title} | ${article.tag} |
Industry Financing Info
Research
Intelligence
0 Research Briefs
Competition
Competitors
5 Competitors
